These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23406073)

  • 1. Does preexisting antiplatelet treatment influence postthrombolysis intracranial hemorrhage in community-treated ischemic stroke patients? An observational study.
    Meurer WJ; Kwok H; Skolarus LE; Adelman EE; Kade AM; Kalbfleisch J; Frederiksen SM; Scott PA
    Acad Emerg Med; 2013 Feb; 20(2):146-54. PubMed ID: 23406073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preexisting dual antiplatelet treatment increases the risk of post-thrombolysis intracranial hemorrhage in Chinese stroke patients.
    Pan Y; Chen Q; Liao X; Zhao X; Wang C; Liu G; Liu L; Wang C; Wang D; Wang Y; Wang Y;
    Neurol Res; 2015 Jan; 37(1):64-8. PubMed ID: 24861494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet pretreatment and outcomes in intravenous thrombolysis for stroke: a systematic review and meta-analysis.
    Tsivgoulis G; Katsanos AH; Zand R; Sharma VK; Köhrmann M; Giannopoulos S; Dardiotis E; Alexandrov AW; Mitsias PD; Schellinger PD; Alexandrov AV
    J Neurol; 2017 Jun; 264(6):1227-1235. PubMed ID: 28550481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IV thrombolysis and statins.
    Engelter ST; Soinne L; Ringleb P; Sarikaya H; Bordet R; Berrouschot J; Odier C; Arnold M; Ford GA; Pezzini A; Zini A; Rantanen K; Rocco A; Bonati LH; Kellert L; Strbian D; Stoll A; Meier N; Michel P; Baumgartner RW; Leys D; Tatlisumak T; Lyrer PA
    Neurology; 2011 Aug; 77(9):888-95. PubMed ID: 21849650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual antiplatelet therapy pretreatment in IV thrombolysis for acute ischemic stroke.
    Tsivgoulis G; Goyal N; Kerro A; Katsanos AH; Krishnan R; Malhotra K; Pandhi A; Duden P; Deep A; Shahripour RB; Bryndziar T; Nearing K; Chulpayev B; Chang J; Zand R; Alexandrov AW; Alexandrov AV
    Neurology; 2018 Sep; 91(11):e1067-e1076. PubMed ID: 30120131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after stroke thrombolysis according to prior antiplatelet use.
    Meseguer E; Labreuche J; Guidoux C; Lavallée PC; Cabrejo L; Sirimarco G; Valcarcel JG; Klein IF; Amarenco P; Mazighi M
    Int J Stroke; 2015 Feb; 10(2):163-9. PubMed ID: 25487908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of early antiplatelet therapy in acute ischemic stroke patients receiving endovascular treatment: A systematic review and meta-analysis.
    Guo Y; Lin Y; Tang Y; Tang Q; Wang X; Pan X; Zou J; Yang J
    J Clin Neurosci; 2019 Aug; 66():45-50. PubMed ID: 31153752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy increases symptomatic ICH risk after thrombolysis and thrombectomy.
    Couture M; Marnat G; Griffier R; Gariel F; Olindo S; Renou P; Sagnier S; Berge J; Tourdias T; Sibon I
    Acta Neurol Scand; 2021 Nov; 144(5):500-508. PubMed ID: 34042170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies.
    Luo S; Zhuang M; Zeng W; Tao J
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes, Predictors, and Timing of Early Neurological Deterioration and Symptomatic Intracranial Hemorrhage After Administration of IV tPA.
    Shah K; Clark A; Desai SM; Jadhav AP
    Neurocrit Care; 2022 Feb; 36(1):123-129. PubMed ID: 34228264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum creatinine may indicate risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator (IV tPA).
    Marsh EB; Gottesman RF; Hillis AE; Urrutia VC; Llinas RH
    Medicine (Baltimore); 2013 Nov; 92(6):317-323. PubMed ID: 24145699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
    Kellert L; Sykora M; Gumbinger C; Herrmann O; Ringleb PA
    Cerebrovasc Dis; 2012; 33(2):135-40. PubMed ID: 22179586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
    Diedler J; Ahmed N; Sykora M; Uyttenboogaart M; Overgaard K; Luijckx GJ; Soinne L; Ford GA; Lees KR; Wahlgren N; Ringleb P
    Stroke; 2010 Feb; 41(2):288-94. PubMed ID: 20056933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
    Bravo Y; Martí-Fàbregas J; Cocho D; Rodríguez-Yáñez M; Castellanos M; de la Ossa NP; Roquer J; Obach V; Maestre J; Martí-Vilalta JL
    Cerebrovasc Dis; 2008; 26(2):126-33. PubMed ID: 18560215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic thrombolysis in acute ischemic stroke patients with unruptured intracranial aneurysms.
    Goyal N; Tsivgoulis G; Zand R; Sharma VK; Barlinn K; Male S; Katsanos AH; Bodechtel U; Iftikhar S; Arthur A; Elijovich L; Alexandrov AW; Alexandrov AV
    Neurology; 2015 Oct; 85(17):1452-8. PubMed ID: 26408492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telemedical Brain Computed Tomography Misinterpretation by Stroke Neurologists Is Not Associated with Thrombolysis-Related Intracranial Hemorrhage.
    Zerna C; von Kummer R; Gerber J; Engellandt K; Abramyuk A; Wojciechowski C; Barlinn K; Kepplinger J; Pallesen LP; Siepmann T; Dzialowski I; Reichmann H; Puetz V; Bodechtel U
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1520-6. PubMed ID: 25873473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.